Literature DB >> 6299513

Monoclonal antibody for identification of human duct cell carcinoma of pancreas.

I Parsa, A L Sutton, C K Chen, C Delbridge.   

Abstract

Monoclonal antibody to duct cell surface marker (HP-DU-1), produced by hybridoma, was shown to be specific to duct cell surface antigen when tested against normal adult and 12-20-week-old fetal human pancreases. There were no common HLA antigens for locus A, B, C and DR among the 10 pancreas donors; nor did HP-DU-1 reveal any affinity for lymphocytes of donors whose pancreases were used as antigen for immunization of BALB/c mice. Seven out of 7 human pancreas adenocarcinomas including a poorly differentiated human pancreatic tumor expressed surface determinants detectable by HP-DU-1. Cell lines CAPAN-1 and CAPAN-2, derived from human pancreatic adenocarcinoma, also revealed the same antigenic determinants.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6299513     DOI: 10.1016/0304-3835(82)90035-0

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Human pancreatic adenocarcinoma-associated antigens defined by novel murine monoclonal antibodies Pak-1 and Pak-2.

Authors:  K Makisumi; K Takahashi; S Takako; S Sonoda
Journal:  Gastroenterol Jpn       Date:  1990-04

2.  Reactivity of monoclonal anti-human pancreatic carcinoma antibodies AR2-20 and AR1-28 with tumors of nonpancreatic origin.

Authors:  J Chin; R Zuna; F Miller
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

3.  The generation of monoclonal antibodies against human pancreatic exocrine cancer: a study of six different immunisation regimes.

Authors:  A G Grant; P M Harris; E Heyderman; S E Larkin; B Pym; J Hermon-Taylor
Journal:  Br J Cancer       Date:  1985-10       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.